Steven Engle

Non-Executive Chairman, Non-Executive Director / Prescient Therapeutics

Most Notable Role

Steven Engle has extensive experience in US capital markets, a record of achievement with big pharma partnering and established links with the US FDA.

As a former chief executive of NASDAQ-listed companies Xoma and La Jolla Pharmaceuticals, he has wide networks in the US and European biotech industries. He is the chief executive of Averigon Consulting, a leading advisory firm to the US life sciences industry, and non-executive chair of Prescient Therapeutics.

Lists and Charts

Roles

2015

Non-Executive Director

Aroa Biosurgery

2014

Non-Executive Chairman, Non-Executive Director

Prescient Therapeutics

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1561^st	Credit Intelligence">Credit Intelligence	-55.9%	-17.39%
1562^nd	Renascor Resources">Renascor Resources	-56%	38.38%
1563^rd	Prescient Therapeutics">Prescient Therapeutics	-56%	-14.45%
1564^th	Micro-X">Micro-X	-56.01%	-24.28%
1565^th	Australasian Metals">Australasian Metals	-56.01%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Aroa Biosurgery

03 Nov 2020

Related Information

Access to our data for Steven Engle is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Steven Engle is linked to 2 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.